Ophthalmic inflammatory diseases, including conjunctivitis, keratitis, uveitis, scleritis, and
related conditions, pose considerable challenges to effective management and treatment …

Objective To summarize evidence regarding efficacy of anti-TNFα in childhood chronic
uveitis, refractory to common DMARDs. Methods An updated systematic search was …

Objective Systemic immunosuppressive treatment of pediatric chronic anterior uveitis (CAU),
both juvenile idiopathic arthritis–associated and idiopathic anterior uveitis, varies, making it …

Pediatric uveitis is a topic of special interest not only because of the unique diagnostic and
therapeutic challenges but also because of the lifetime burden of vision loss if the problem is …

Objective To summarize updated evidences on the efficacy and safety of adalimumab (ADA)
in the treatment of patients with non-infectious uveitis. Patients and methods A systematic …

Aims To evaluate the safety and efficacy of intravitreal injection of liposomes encapsulating
infliximab in experimental autoimmune uveoretinitis (EAU) rats. Methods Liposomes …

Purpose To study the drug retention rate (DRR), causes, and predictors of discontinuation of
adalimumab (ADA) in a real-world uveitis setting. Design Multicentric, nationwide, registry …

Uveitis is the third leading cause of blindness in developed countries. Currently, the most
widely used treatment of non-infectious uveitis is corticosteroids. Posterior uveitis and …

What is new in paediatric uveitis? : Current Opinion in Ophthalmology What is new in paediatric
uveitis? : Current Opinion in Ophthalmology Log in or Register Subscribe to journalSubscribe …

Anterior uveitis (AU), inflammation of the iris, choroid or ciliary body, can cause significant
eye morbidity, including visual loss. In the pediatric age group, the most common underlying …